Company: PTPI
Filing Date: 2025-02-10
Form Type: S-1/A
Source: 0001410578-25-000108
Chunk: 228

Company: Petros Pharmaceuticals, Inc.
Filing Date: 2025-02-10
Form: S-1/A
Chunk 228
---
 Term | ​ 
 ​ 
 ​ 
 ​ | ​           
 Aggregate   
 Intrinsic   
 Value ($ in 
 thousands)  | ​ |
|:-----------------------------------------|:--|-------------------:|:--|:-----------------|-------:|:--|-----------------:|:--|:------------|:--|
| Warrants outstanding - December 31, 2021 |   |          1,004,115 | ​ | $                | 105.85 | ​ |              4.5 | ​ | $           | — |
| Warrants issued in 2022                  |   |                  — | ​ | ​                |      — | ​ |                — | ​ | ​           | — |
| Warrants outstanding - December 31, 2022 | ​ |          1,004,115 | ​ | $                | 105.85 | ​ |              3.5 | ​ | $           | — |
| Warrants issued in 2023                  | ​ |          7,200,002 | ​ | ​                |   2.25 | ​ |                ​ | ​ | ​           | ​ |
| Warrants expired in 2023                 | ​ |               -278 | ​ | ​                | -16.00 | ​ |                ​ | ​ | ​           | ​ |
| Warrants outstanding - December 31, 2023 |   |          8,203,839 | ​ | $                |  14.93 | ​ |              4.3 | ​ | $           | — |

F-22

#### 13)    Dilutive convertible securitiesThe following table summarizes the potentially dilutive securities convertible into common shares that were excluded from the calculation of diluted net loss per share because their inclusion would have been antidilutive:​​​​​​​​For the Years Ended​​December 31,​20232022Stock options509,13359,067RSUs​—​40,238Series A Convertible Preferred stock​5,985,519​—Warrants8,203,8391,004,115Total14,698,4911,103,420​​14)   Marketing, Licensing and Distribution Agreements(a)    VivusOn September 30, 2016, the Company entered into a License and Commercialization Agreement (the “License Agreement”) with Vivus, Inc (“Vivus”) to purchase and receive the license for the commercialization and exploitation of Stendra® for